Rafael Holdings, Inc. (RFL) Phase 3 Misses Primary Endpoint; Subgroup Met Significance

Rafael Holdings reported Trappsol Cyclo’s Phase 3 did not reach statistical significance on the primary endpoint, while a prespecified subgroup on miglustat and/or leucine showed a statistically significant effect. The company plans to submit an NDA in Q4 2026.Material DetailsContext by AI AnalystT…